Traynor Capital Management Inc. Sells 191 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Traynor Capital Management Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 858 shares of the healthcare conglomerate’s stock after selling 191 shares during the period. Traynor Capital Management Inc.’s holdings in UnitedHealth Group were worth $434,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Independent Wealth Network Inc. grew its stake in shares of UnitedHealth Group by 27.8% in the 4th quarter. Independent Wealth Network Inc. now owns 464 shares of the healthcare conglomerate’s stock valued at $235,000 after purchasing an additional 101 shares during the period. Wesbanco Bank Inc. raised its stake in UnitedHealth Group by 4.8% during the fourth quarter. Wesbanco Bank Inc. now owns 51,868 shares of the healthcare conglomerate’s stock worth $26,238,000 after acquiring an additional 2,365 shares in the last quarter. Sharp Financial Services LLC boosted its stake in shares of UnitedHealth Group by 11.0% in the 4th quarter. Sharp Financial Services LLC now owns 885 shares of the healthcare conglomerate’s stock valued at $447,000 after purchasing an additional 88 shares in the last quarter. Phillips Wealth Planners LLC lifted its holdings in UnitedHealth Group by 4.4% during the 4th quarter. Phillips Wealth Planners LLC now owns 2,767 shares of the healthcare conglomerate’s stock valued at $1,441,000 after purchasing an additional 117 shares during the last quarter. Finally, Kelleher Financial Advisors grew its stake in UnitedHealth Group by 1.3% during the fourth quarter. Kelleher Financial Advisors now owns 3,315 shares of the healthcare conglomerate’s stock worth $1,677,000 after buying an additional 43 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $519.08 on Thursday. The business has a 50-day moving average of $545.26 and a 200-day moving average of $564.10. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $477.70 billion, a price-to-earnings ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.